Corvus Pharmaceuticals (CRVS) Stock Chart & Stock Price History $4.71 -0.04 (-0.84%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$4.80 +0.09 (+1.80%) As of 07/25/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Corvus Pharmaceuticals Stock Price Performance The Corvus Pharmaceuticals (CRVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 82.56%, with a year-to-date return of -11.96%. In the past month, the stock has increased 11.88%, reflecting recent market activity. As of the latest close, Corvus Pharmaceuticals traded at $4.71 with a market cap of $321.08 million and volume of 404,908 shares. Five years ago, the stock traded at $4.29, representing a 9.79% increase over that period. At the time, it had a market cap of $116.43 million and a volume of 272,390 shares. Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.84%1 Month Performance+11.88%3 Month Performance+29.75%Year-To-Date Performance-11.96%1 Year Performance+82.56%5 Year Performance+9.79% CRVS Stock Chart for Saturday, July, 26, 2025 CRVS Chart by TradingView Corvus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$4.75$4.71-0.84%$4.78$4.58404,908 shs$321.08 million07/24/2025$4.67$4.75+1.71%$4.98$4.61760,222 shs$323.81 million07/23/2025$4.33$4.67+7.85%$4.73$4.39707,908 shs$318.35 million07/22/2025$4.45$4.33-2.70%$4.53$4.30433,387 shs$295.18 million07/21/2025$4.26$4.45+4.46%$4.53$4.30526,584 shs$290.74 million07/18/2025$4.25$4.26+0.24%$4.43$4.24441,874 shs$290.40 million07/17/2025$4.25$4.25$4.32$4.22371,387 shs$289.72 million07/16/2025$4.17$4.25+1.92%$4.28$4.09342,475 shs$289.72 million07/15/2025$4.35$4.17-4.14%$4.38$4.13434,657 shs$284.27 million07/14/2025$4.14$4.35+5.07%$4.36$4.15368,655 shs$296.54 million Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$4.25$4.14-2.59%$4.23$4.07358,779 shs$282.22 million07/10/2025$4.18$4.25+1.67%$4.31$4.10471,369 shs$289.72 million07/09/2025$3.96$4.18+5.56%$4.21$3.96541,479 shs$284.95 million07/08/2025$3.90$3.96+1.54%$4.00$3.86504,370 shs$269.95 million07/07/2025$3.94$3.90-0.89%$3.93$3.79696,912 shs$265.86 million07/04/2025$3.94$3.94$4.07$3.94313,955 shs$268.25 million07/03/2025$3.98$3.94-1.13%$4.07$3.94313,955 shs$268.25 million07/02/2025$3.86$3.98+3.11%$4.09$3.78728,119 shs$271.32 million07/01/2025$4.00$3.86-3.50%$4.04$3.711.29 million shs$263.14 million06/30/2025$3.89$4.00+2.83%$4.00$3.71970,972 shs$272.68 million06/27/2025$4.21$3.89-7.60%$4.25$3.787.68 million shs$265.18 million06/26/2025$4.12$4.21+2.18%$4.21$3.98867,912 shs$287.00 million06/25/2025$4.34$4.12-5.07%$4.38$3.911.15 million shs$280.86 million Related Companies Enliven Therapeutics Stock Price Chart Structure Therapeutics Stock Price Chart Cidara Therapeutics Stock Price Chart Ardelyx Stock Price Chart Praxis Precision Medicines Stock Price Chart ProKidney Stock Price Chart Collegium Pharmaceutical Stock Price Chart Akebia Therapeutics Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Arcus Biosciences Stock Price Chart Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRVS) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
